Jammu to get 240-bed bone and joint hospital: minister

Jammu, Apr 22 : A 240-bedded bone and joint hospital is coming up here for the benefit of patients who have to rush to Srinagar or outside the state for specialised treatment, Jammu and Kashmir Health minister Bali Bhagat said today.

Bhagat laid the foundation of the hospital which will be completed at a cost of Rs 40.45 crore on the land adjacent to the government chest diseases hospital here, an official spokesman said.

He said the project comprises a four-storey building which is likely to be completed within a period of two years by the Public Works Department (Roads and Buildings).

Jammu and Kashmir has only one bone and joint hospital at Srinagar which was established in 1972.

“The construction of the hospital was a long pending demand of the people of Jammu as a majority of the patients from the division and critical accidental cases used to move to Srinagar and adjoining states for treatment,” the minister said.

He said the government has decided to set up an exclusive bone and joint hospital in Jammu and its establishment would be a great relief to the poor patients, especially to critical accidental cases, and also ease out the extra ordinary flow of patients in the hospital in Srinagar.

He said the project has been approved under Prime Minister’s Development Package and the hospital would have the provisions of all ultra modern gadgets and diagnostic facilities. The process for creation of faculty and other staff has also been set in motion, he said. TAS ADS ADS

  • Related Posts

    Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

    AiMeD welcomes the move long overdue to boost India’s Regulatory Framework New Delhi: 21 Drug Inspectors have been promoted to Assistant Drugs Controllers (India) under CDSCO. It was long unmet…

    Yashoda Medicity lifts Benchmark in Critical Care to New High

    With the introduction of North India’s first Advanced VitalGo Total Lift Bed Technology Ghaziabad/ New Delhi: In an ideal hospital, critical care is most paramount and it is also the…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad